Harman Patil (Editor)

Medazepam

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Trade names
  
Rudotel

ATC code
  
N05BA03 (WHO)

CAS ID
  
2898-12-6

Routes of administration
  
Oral

Molar mass
  
270.8 g/mol

Medazepam

AHFS/Drugs.com
  
International Drug Names

Legal status
  
CA: Schedule IV DE: Anlage III (Prescription only) US: Schedule IV

Bioavailability
  
50–75% (Сmax = 1–2 hours)

Medazepam is a drug that is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties. It is known by the following brand names: Azepamid, Nobrium, Tranquirax (mixed with bevonium), Rudotel, Raporan, Ansilan and Mezapam. Medazepam is a long-acting benzodiazepine drug. The half-life of medazepam is 36–200 hours.

Pharmacology

Benzodiazepine drugs including medazepam increase the inhibitory processes in the cerebral cortex by allosteric modulation of the GABA receptor. Benzodiazepines may also act via micromolar benzodiazepine-binding sites as Ca2+ channel blockers and significantly inhibited depolarization-sensitive calcium uptake in experiments with cell components from rat brains. This has been conjectured as a mechanism for high dose effects against seizures in a study. It has major active benzodiazepine metabolites, which gives it a more prolonged therapeutic effects after administration.

References

Medazepam Wikipedia